Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3137113 | 1.00 | UHRF1 (0.30) | UHRF1 | |
| Trifluoroacetic Acid SCHEMBL3134000 | 0.83 | UHRF1 (0.31) | UHRF1 | |
| Trifluoroacetic Acid SCHEMBL3133993 | 0.83 | UHRF1 (0.31) | UHRF1 | |
| Trifluoroacetic Acid SCHEMBL3137097 | 0.83 | UHRF1 (0.31) | UHRF1 | |
| SCHEMBL3137102 | 0.78 | — | — | |
| SCHEMBL3137108 | 0.78 | — | — | |
| Trifluoroacetic Acid SCHEMBL3126565 | 0.75 | CA12 (0.42) | — | |
| Trifluoroacetic Acid SCHEMBL3126576 | 0.75 | CA12 (0.42) | — | |
| Trifluoroacetic Acid SCHEMBL3135848 | 0.75 | CA12 (0.42) | — | |
| Trifluoroacetic Acid SCHEMBL29139510 | 0.72 | UHRF1 (0.34) | UHRF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010056633-A2 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA NV (BE) | 2010-05-20 | — | — | WO | disclosed |
| US-20090156577-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA NV (BE) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156577-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | NQO2, QRFPR, NQO1 | UHRF1 2713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.